GlassScriptPhysician profile
Joshua Pan
NPI 1972113074
$8,484.26
in general payments reported to CMS, 2019-2025
31 companies · $1,807 in 2025
The $1,807 reported for 2025 was more than what 92% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,068 · 2022: $1,191 · 2023: $2,049 · 2024: $1,370 · 2025: $1,807.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,852 · Education: $373.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,852.07 |
| Education | $373.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $933.74 | 2021-2025 | Tremfya, Stelara, Simponi Aria |
| Incyte Corporation | $663.33 | 2021-2025 | Opzelura, Opzelura |
| Abbvie INC. | $574.14 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $562.64 | 2021-2024 | Ilumya |
| Dermavant Sciences, INC. | $484.78 | 2023-2024 | Vtama |
| Regeneron Healthcare Solutions, INC. | $474.96 | 2021-2025 | Dupixent, Libtayo |
| E.R. Squibb & Sons, L.L.C. | $467.80 | 2023-2025 | Sotyktu |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $460.04 | 2021-2024 | Jublia, Arazlo, Cabtreo |
| Arcutis Biotherapeutics, INC. | $452.69 | 2023-2024 | Zoryve |
| Genzyme Corporation | $426.29 | 2021-2023 | |
| Lilly USA, LLC | $421.47 | 2021-2025 | Olumiant, Ebglyss, Taltz |
| Pfizer INC. | $328.05 | 2021-2024 | |
| Journey Medical Corporation | $318.60 | 2021-2022 | |
| Galderma Laboratories, L.P. | $310.15 | 2021-2025 | Aklief, Oracea, Nemluvio |
| Botanix Sb INC | $308.52 | 2025 | Sofdra |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $235.42 | 2021-2025 | Bimzelx |
| Janssen Scientific Affairs, LLC | $198.94 | 2021 | |
| Leo Pharma INC. | $193.50 | 2021-2023 | Adbry |
| Vyne Pharmaceuticals INC. | $104.43 | 2021 | |
| Amgen INC. | $98.33 | 2021 | |
| Epi Health, LLC | $85.30 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $79.99 | 2021 | |
| Novartis Pharmaceuticals Corporation | $75.34 | 2021 | |
| Ani Pharmaceuticals, INC. | $38.87 | 2023 | Purified Cortrophin Gel |
| Strata Skin Sciences, INC. | $34.25 | 2023 | Xtrac |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.92 | 2024 | Spevigo |
| Genentech USA, INC. | $29.05 | 2022 | |
| Organon LLC | $28.28 | 2025 | |
| Mayne Pharma Commercial LLC | $23.09 | 2022 | |
| Biofrontera INC. | $21.05 | 2023 | Ameluz, Xepi, Bf-Rhodoled |
| Dermira, INC. | $20.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Pan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.